Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2025-10-01
2029-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Data from the investigators lab and others show that when eating plant foods, combining grains and legumes like rice and beans, peanut butter and bread, (protein complementation) will provide a complete protein which contains all the amino acids needed by the body. However, some maintain that it is not necessary to combine foods like grains and legumes in the same meal as long as all the amino acids are consumed within a 24h period. This has never been tested.
The goal of this study is to compare the effects non-complementation to protein complementization on whole body protein metabolism in young and older adults.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of a Whole-food Animal-based Versus Plant-based Protein Rich Meal on Muscle Protein Synthesis
NCT05151887
Improving the Anabolic Action of Plant-based Foods Using Complementary Proteins
NCT06781723
Aminoacidemia and Protein Kinetics in Response to the Ingestion of Plant-based Protein Blends
NCT05139160
The Impact of Plant-based Blends on Skeletal Muscle Protein Synthesis Rates in Older Adults
NCT05917223
Mycoprotein as the Basis of a Sustainable Diet to Support Muscle Mass Maintenance and Reconditioning in Older Adults.
NCT04325178
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Skeletal muscle plays an important role in the adaptations of body proteins to nutritional changes and during stress. Therefore, knowledge of skeletal muscle response to changes in dietary protein intake from animal to plant based protein is an important prerequisite to understand the body's capacity, especially in the elderly, to adapt to alterations in dietary protein quality from animal to plant based, whether in complementation or non-complementation fashion. The contribution of skeletal muscle to protein breakdown is calculated by measuring urinary 3-methylhistidine. This amino acid is produced in muscle from post-translational modification of histidine and released from actin and myosin. It is not reutilized for protein synthesis but is excreted in the urine. Therefore, the urinary output of 3-methylhistidine is a quantitative index of daily muscle protein breakdown.
Objectives:
1. To assess whole-body protein metabolism (WBPM) (protein synthesis, protein breakdown and protein balance) using a single dose \[15N\]glycine and measuring cumulative excretion of \[15N\]urea in urine in human adult consuming a PB diet provided in a complementary or non-complementary fashion in males and females 18 -39, 60-69 and 70-79 years and
2. To assess the contribution of skeletal muscle to protein breakdown by measuring urinary 3-methyhistidine.
Hypothesis:
Protein synthesis and balance will be lower, but breakdown will be higher in the non-complementation PB diets compared to omnivorous diet (control) and lacto-vegetarian diet.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
protein synthesis, breakdown and balance assessed after exposure to 5 diets consumed over 9d
Diet, whole food provided to participants over 5 x 9 day period
5 diets provided to participants over 9 days each and whole body protein synthesis, protein breakdown and protein balance assessed after each period.
Diet
5 different diet types
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diet, whole food provided to participants over 5 x 9 day period
5 diets provided to participants over 9 days each and whole body protein synthesis, protein breakdown and protein balance assessed after each period.
Diet
5 different diet types
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults, age 18 - 39 yrs, Healthy with no known clinical condition which would affect protein or AA metabolism, ex. Diabetes, Stable Body Weight (no more than 5 lb weight loss or gain in the past 3 months)
* Not on any medications that could affect protein or amino acid metabolism e.g. steroids.
* Fasting blood glucose, hemoglobin A1C (HbA1c), urea and creatinine within normal ranges for age.
2\) Older Adults:
* Adults, aged 60-69 and 70-79 years, Healthy with no known clinical condition which would affect protein or AA metabolism, ex. Diabetes, Stable Body Weight (no more than 5 lb weight loss or gain in the past 3 months)
* Not on any medications that could affect protein or amino acid metabolism e.g. steroids,
* Fasting blood glucose, hemoglobin A1C (HbA1c), urea and creatinine within normal ranges for age.
Exclusion Criteria
* Recent history of weight loss within the last 3 months or on a weight reducing diet Inability to tolerate study diets (ex. Allergy to ingredients).
* Significant caffeine consumption (\>2 cups per day)
* Significant alcohol consumption (\>1 drink per day i.e. 1 beer or ½ glass of wine).
* Fasting blood glucose, hemoglobin A1C (HbA1c), urea and creatinine outside of normal ranges for age.
* On medications known to affect protein and AA metabolism, renal failure, liver disease, unable to ambulate independently.
18 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Hospital for Sick Children
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Glenda Courtney-Martin
Senior Associate Scientist- Translational Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Glenda Courtney-Martin, PhD, RD
Role: PRINCIPAL_INVESTIGATOR
Research Institute, The Hospital for Sick Children
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Hospital for Sick Children
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PJT-198014
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
3667
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.